Recursion Archives - AI Insider

AI Drug Discovery Space Leaders Recursion And Exscientia Officially Combine

Insider Brief Recursion and Exscientia announced their business combination has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion. Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs,

20 Nov 2024 · 4 min read

Recursion

AI Drug Discovery Space Leaders Recursion And Exscientia Officially Combine

Trending today

SpaceX Returns to Profit as AI Business Drives Over Half of Third-Quarter Income

AI Companion Tolan Secures $30M as It Gains Traction in a Crowded Field

Hugging Face Leaders Question AI Evaluation Standards and Netflix’s Portrayal of Rogue Agents

CoreWeave Launches Physical AI Templates for Robotics and AV Development

Pigment Raises $250M at $2.3B Valuation

Recursion

AI Drug Discovery Space Leaders Recursion And Exscientia Officially Combine

Trending today

SpaceX Returns to Profit as AI Business Drives Over Half of Third-Quarter Income

AI Companion Tolan Secures $30M as It Gains Traction in a Crowded Field

Hugging Face Leaders Question AI Evaluation Standards and Netflix’s Portrayal of Rogue Agents

CoreWeave Launches Physical AI Templates for Robotics and AV Development

Pigment Raises $250M at $2.3B Valuation

The AI economy, every weekday morning